This question has been answered by the relevant Government Department.
Question text
Lord Alton of Liverpool to ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 21 April (HL2602), why they have not been in contact with the National Cancer Institute Pascale Foundation or the Colli Hospital in Italy to assess the potential outcomes of the use of Tocilizumab to treat patients with COVID-19 related pneumonia; how they are monitoring “the results of trials of experimental therapies for COVID-19 from around the world”; what discussions they plan to have with the National Cancer Institute Pascale Foundation, and the Colli Hospital in Italy as part of that monitoring; whether the United Kingdom Therapeutics Task Force will report on its findings of its assessment of tocilizumab; and if so, when. HL2997
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Member's Registered Interests
There are no interests to show.
Main Member
Lord Alton of Liverpool
Crossbench
Life peer